Chromosome changes caused by alterations of p53 expression

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 354, Issue 1, 1996, Pages 129-138

  Agapova, Larissa S ^a   Ilyinskaya, Galina V ^a   Turovets, Nikolai A ^a   Ivanov, Alexey V ^b   Chumakov, Peter M ^b   Kopnin, Boris P ^a  

^a Cancer Research Center   (Russian Federation)

^b ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

Chromosome break; Heteroploidy; Karyotype; p53 Tumor suppressor

Indexed keywords

CAFFEINE; PROTEIN P53;

ALLELE; ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL STRAIN 3T3; CHROMOSOME BREAKAGE; CONTROLLED STUDY; DNA DAMAGE; HUMAN; HUMAN CELL; KARYOTYPE; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANIMALIA; MAMMALIA; MURINAE;

EID: 0030570448     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/0027-5107(96)00062-0     Document Type: Article

References (45)

1. Baker, S.J., A.C. Preisinger, J.M. Jessup, C. Paraskeva, S. Markowitz, J.K.V. Wilson, S. Hamilton and B. Vogelstein (1990) p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis, Cancer Res., 50, 7717-7722.
2. Bischoff, F.Z., S.O. Yim, S. Pathak, G. Grant, M.J. Siciliano, B.C. Giovanella, L.C. Strong and MA. Tainsky (1990) Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization, Cancer Res., 50, 7979-7984.
3. Carder, P., A.M. Wyllie, C.A. Purdie, R.G. Morris, S. White, J. Piris and C.C. Bird (1993) Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer, Oncogene, 3, 1397-1401.
4. Chumakov, A.M., C.W. Miller, D.L. Chen and H.P. Koeffler (1993) Analysis of p53 transactivation through high-affinity binding-sites, Oncogene, 8, 3005-3011.
5. Clarke, A.R., C.A. Purdie, D.J. Harrison, R.G. Morris, C.C. Bird. M.L. Hooper and A.H. Wyllie (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways, Nature, 362, 849-852.
6. Cox, L.S., T. Hupp, C.A. Midgley and D.P. Lane (1995) A direct effect of activated human p53 on nuclear DNA replication, EMBO J., 14, 2099-2105.
7. Cross, S.M., C.A. Sanches, C.A. Morgan, M.K. Schimke, S. Ramel, R.L. Idzerda, W.H. Raskind and B.J. Reid (1995) A p53-dependent mouse spindle checkpoint, Science, 267, 1353-1356.
8. Deb, S., C.T. Jackson, M.A. Subler and D.W. Martin (1992) Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells, J. Virol., 66, 6164-6170.
9. Dittmer, D., S. Pati, G. Zambetti, S. Chu, A.K. Teresky, M. Moore, C. Finlay and A.J. Levine (1993) Gain of function mutations in p53, Nature Genet., 4, 42-46.
10. Donehover, L.A., M. Harvey, B.L. Slagle, M.G. McArthur, C.A. Montgomery Jr., J.S. Butel and A. Bradley (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
11. Dulič, V., W.K. Kaufmann, S.J. Wilson, T.D. Tlsty, M. Lees, W. Harper, S.J. Elledge and S.I. Reed (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest, Cell, 76, 1013-1023.
12. Dutta, A., J.M. Ruppert, J.C. Aster and E. Winchester (1993) Inhibition of DNA replication factor RPA by p53, Nature, 365, 79-82.
13. El-Deiry, W.S., T. Tokino, P.M. Velculescu, D.B. Levy, B. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler and B. Vogelstein (1993) WAF1, a potential mediator of p53 tumor suppression, Cell, 75, 817-825.
14. 1, arrest and apoptosis, Science, 262, 1644-1645.
15. Fritsche, M., C. Haessler and G. Brandler (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents, Oncogene, 8, 307-318.
16. Gannon, J.V., R. Greaves, R. Iggo and D.P. Lane (1990) Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for mutant form, EMBO J., 9, 1595-1602.
17. Harlow, E., L.V. Crawford, D.C. Pim and N.M. Williamson (1981) Monoclonal antibodies specific for Simian virus 40 tumor antigen, J. Virol., 39, 861-869.
18. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi and G.J. Elledge (1993) The p21Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, Cell, 75, 805-816.
19. Hartwell, L.H. and M.B. Kastan (1994) Cell cycle control and cancer, Science, 266, 1821-1828.
20. Harvey, D. and A.J. Levine (1991) p53 alteration is a common event in the spontaneous immortalization of primary BALB/C murine embryo fibroblasts, Genes Dev., 5, 2375-2385.
21. Harvey, M., A.T. Sands, R.S. Weiss, M.E. Heig, R.W. Wiseman, P. Pantazis, B.O. Clovanello, M.A. Tainsky, A. Bradley and L.A. Donehower (1993) In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice, Oncogene, 8, 2456-2467.
22. Hollstein, M., D. Sidransky, B. Vogelstein and C.C. Harris (1991) p53 mutations in human cancers, Science, 253, 49-53.
23. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein and R.W. Craig (1991) Participation of p53 protein in the cellular response to DNA damage, Cancer Res., 51, 6304-6311.
24. Kopnin, B.P., T.P. Stromskaya, R.V. Kondratov, V.S. Ossovskaya, E.N. Pugacheva, E.Y. Rybalkina, O.A. Khokhlova and P.M. Chumakov (1995) Influence of exogenous RAS and P53 on P-glycoprotein function in immortalized rodent fibroblasts, Oncology Res., 7, 299-306.
25. Lane, D.P. (1992) p53, guardian of the genome, Nature, 358, 15-16.
26. Lee, J.M., L.A. Abrahamson, R. Kandel, L.A. Donehower and A. Bernstein (1994) Susceptibility to radiation-carcinogenesis and accumulation of chromosomal breakage in p53 deficient mice, Oncogene, 9, 3731-3736.
27. Levine, A.J., M.E. Perry, A. Chang, A. Silver, D. Dittmer, M. Wu and D. Welsh (1994) The 1993 Walter Hubert Lecture: The role of the p53 tumour-suppressor gene in tumourigenesis, Br. J. Cancer, 69, 409-416.
28. Livingstone, L.R., A. White, J. Sprouse, E. Livanos, T. Jacks and T.D. Tlsty (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53, Cell, 70, 923-935.
29. Lowe, S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne and T. Jacks (1993) p53 is required for radiation-induced apoptosis in mouse thymocytes, Nature, 362, 847-849.
30. Maltzman, W. and L. Czyzyk (1984) UV irradiation stimulates levels of p53 cellular tumour antigen in nontransformed mouse cells, Mol. Cell. Biol., 4, 1689-1694.
31. Milner, J., E.A. Metcalf and A.C. Cook (1991) Tumor suppressor p53 analysis of wild-type and mutant p53 complexes, Mol, Cell. Biol., 11, 12-19.
32. Nelson, W.G. and M.B. Kastan (1994) DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways, Mol. Cell, Biol., 14, 1815-1823.
33. Niewolik, D., B. Vojetesek and J. Kovarik (1995) p53 derived from human tumour cell lines and containing distinct point mutations can be activated to bind its consensus target sequence, Oncogene, 10, 881-890.
34. Ossovskaya, V.S., B.P. Kopnin, E.A. Smirnova, N.T. Raikhlin and P.M. Chumakov (1995) Cell-specific effects of p53 cD-NAs governed by homologous promoter, Mol. Biol., 29, 32-38.
35. Ozkinay, C. and F. Mitelman (1979) A simple trypsin-Giemsa technique producing simultaneous G- and C-banding in human chromosomes, Hereditas, 90, 1-4.
36. Park, D.J., H. Nakamura, A.M. Chumakov, J.N. Said, C.W. Miller, D.L. Chen and H.P. Koeffler (1994) Transactivational and DNA binding abilities of endogenous p53 in p53 mutant cell lines, Oncogene, 9, 1899-1906.
37. Smith, M.L., I.T. Chen, Q. Zhan, P.M. O'Connor and A.J.J. Fornace (1995) Involvement of the p53 tumor suppressor in repair of u.v.-type DNA damage, Oncogene, 10, 1053-1059.
38. Tsukada, T., Y. Tomooka, S. Takai, Y. Ueda, S. Nishikawa, T. Yagi, T. Tokunaga, N. Takeda, Y. Suda, S. Abe, I. Matsuo, Y. Ikawa and S. Aizawa (1993) Enhanced proliferative potential in culture of cells from p53-deficient mice, Oncogene, 8, 3313-3322.
39. Waga, S., G.J. Hannon, D. Beach and B. Stillman (1994) The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA, Nature, 369, 574-578.
40. White, A.E., E.M. Livanos and T.D. Tlsty (1994) Differential disruption of genomic integrity and cell cycle regulation in human fibroblasts by the HPV oncoproteins, Genes Dev., 8, 667-677.
41. Whitehead, R.H., F.A. Macrae, D.J.B. John and L. Ma (1985) A colon cancer cell line (LIM 1215) derived from a patient with inherited nonpolyposis colorectal cancer, J. Natl. Cancer Inst., 74, 759-765.
42. Yin, Y., M.A. Tainsky, F.Z. Bishoff, L.C. Strong and G.M. Wahl (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles, Cell, 70, 937-948.
43. Zaichuk, T.A., N.V. Kuznetsov, V.S. Ossovskaya, B.P. Kopnin and P.M. Chumakov (1993) Specific DNA-binding properties of p53 oncoprotein from human tumor cell lines, Proc. Russian Acad. Sci., 330, 386-389.
44. Zambetti, G.P. and A.J. Levine (1993) A comparison of the biological activities of wild type and mutant p53, FASEB J., 7, 855-865.
45. Zhan, Q., K.A. Lord, J.J. Alamo, M.C. Hollander, F. Carrier, D. Ron, W.W. Kohn, B. Huffman, D.A. Lieberman. A.J.J. Fornace (1994) The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth, Mol. Cell. Biol., 14, 2361-2371.